» MedWatch Safety Alert RSS Feed Subscribe to this Feed Add this Content to Your Site • Birth Control Pills Containing Drospirenone: Possible Increased Risk of Blood Clots


• Xigris [drotrecogin alfa (activated)]: Market Withdrawal – Failure to Show Survival Benefit


• Chantix (varenicline)


• Zyvox (linezolid): Drug Safety Communication – Serious CNS Reactions Possible When Given to Patients Taking Certain Psychiatric Medications


• Methylene Blue: Drug Safety Communication – Serious CNS Reactions Possible When Given to Patients Taking Certain Psychiatric Medications


• Nostrilla Nasal Decongestant: Recall – Bacterial Contamination


• CooperVision Avaira Toric Soft Contact Lenses: Class 1 Recall- Unintended Residue on Lenses

• Sprycel (dasatinib): Drug Safety Communication – Risk of Pulmonary Arterial Hypertension